Back to Search
Start Over
NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK.
- Source :
-
Immunity [Immunity] 2011 Jun 24; Vol. 34 (6), pp. 843-53. - Publication Year :
- 2011
-
Abstract
- Tight regulation of NF-κB signaling is essential for innate and adaptive immune responses, yet the molecular mechanisms responsible for its negative regulation are not completely understood. Here, we report that NLRX1, a NOD-like receptor family member, negatively regulates Toll-like receptor-mediated NF-κB activation. NLRX1 interacts with TRAF6 or IκB kinase (IKK) in an activation signal-dependent fashion. Upon LPS stimulation, NLRX1 is rapidly ubiquitinated, disassociates from TRAF6, and then binds to the IKK complex, resulting in inhibition of IKKα and IKKβ phosphorylation and NF-κB activation. Knockdown of NLRX1 in various cell types markedly enhances IKK phosphorylation and the production of NF-κB-responsive cytokines after LPS stimulation. We further provide in vivo evidence that NLRX1 knockdown in mice markedly enhances susceptibility to LPS-induced septic shock and plasma IL-6 level. Our study identifies a previously unrecognized role for NLRX1 in the negative regulation of TLR-induced NF-κB activation by dynamically interacting with TRAF6 and the IKK complex.<br /> (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Cell Line
Cytokines immunology
Humans
I-kappa B Kinase metabolism
Lipopolysaccharides immunology
Mice
Mitochondrial Proteins metabolism
NF-kappa B immunology
NF-kappa B metabolism
Phosphorylation
Protein Binding
TNF Receptor-Associated Factor 6 metabolism
Ubiquitination
I-kappa B Kinase immunology
Mitochondrial Proteins immunology
Signal Transduction
TNF Receptor-Associated Factor 6 immunology
Toll-Like Receptors immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1097-4180
- Volume :
- 34
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Immunity
- Publication Type :
- Academic Journal
- Accession number :
- 21703539
- Full Text :
- https://doi.org/10.1016/j.immuni.2011.02.022